| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 32,63% | 39,52% | · | · |
| VONTOBEL FUND-EMERGING MARKETS EQUITY I EUR CAP | RVI EMERGENTES | 32,63% | 51,68% | 22,06% | 56,11% |
| YIS MSCI JAPAN UNIVERSAL Z | RVI JAPÓN | 32,63% | · | · | · |
| BGF EMERGING MARKETS A2 CZK | RVI EMERGENTES | 32,62% | 51,47% | 20,00% | · |
| INVESCO EMERGING MARKETS EQUITY A CAP USD | RVI EMERGENTES | 32,62% | 85,58% | · | · |
| PICTET - BIOTECH HI EUR | RVI BIOTECNOLOGÍA | 32,62% | 85,42% | 40,15% | 104,43% |
| SCHRODER ISF JAPANESE OPPORTUNITIES C ACC JPY | RVI JAPÓN VALOR | 32,62% | 63,43% | 75,51% | 130,26% |
| INVESCO EMERGING MARKETS EQUITY A CAP EUR | RVI EMERGENTES | 32,61% | · | · | · |
| RURAL EMERGENTES RENTA VARIABLE, FI CARTERA | RVI EMERGENTES | 32,61% | 71,82% | 39,70% | · |
| AVIVA INVESTORS - GLOBAL EMERGING MARKETS INDEX I USD | RVI EMERGENTES | 32,59% | 76,61% | 56,21% | 122,96% |
| CARMIGNAC PORTFOLIO EMERGENTS A EUR YDIS | RVI EMERGENTES | 32,59% | 62,14% | 37,77% | · |
| PIMCO COMMODITY REAL RETURN E (HEDGED) EUR CAP | RVI MATERIAS PRIMAS | 32,59% | 42,13% | 39,62% | 64,30% |
| AMUNDI JAPAN TOPIX UCITS ETF DAILY CHF HEDGED CAP | RVI JAPÓN | 32,58% | 88,98% | 154,50% | · |
| GAMAX FUNDS - ASIA PACIFIC I EUR | RVI ASIA PACÍFICO | 32,58% | 69,78% | 31,28% | 96,79% |
| OFI INVEST ENERGY STRATEGIC METALS RFC USD H | RVI MATERIAS PRIMAS | 32,58% | 44,62% | · | · |
| PICTET - JAPAN INDEX I JPY | RVI JAPÓN | 32,56% | 66,88% | 64,84% | 140,64% |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY SEED (EUR) N CAP | RVI EMERGENTES | 32,55% | 79,31% | 14,61% | 11,74% |
| PICTET - JAPAN INDEX P EUR | RVI JAPÓN | 32,55% | 66,29% | 63,30% | 137,13% |
| PICTET - SECURITY R USD | RVI OTROS SECTORES | 32,55% | 63,13% | 35,54% | 148,72% |
| UBS CORE MSCI JAPAN UCITS ETF HCHF ACC | RVI JAPÓN | 32,55% | 90,50% | 157,17% | · |
